Although bioinformatics analysis has revealed a correlation between SLC1A5 expression and the prognosis of glioma patients [36], the precise role of SLC1A5 and its relationship with the immune status of glioma patients and immunotherapy remain unclear. Here, SLC1A5 is linked to central nervous system cancer.